Harvard School of Public Health (HSPH)
hsph.harvard.eduLive pipeline data from ClinicalTrials.gov, refreshed daily.
Total trials
153
Active
18
Phase 3
20
Total enrollment
2,493,770
Pipeline matrix
Showing 5 of 5 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| DTG/ABC/3TC | — | — | — | — | — | 1 | |
| Kaletra | — | — | — | — | — | 1 | |
| Lamivudine | — | — | — | — | — | 1 | |
| Zidovudine | — | — | — | — | — | 1 | |
| Nevirapine | — | — | — | — | 2 |
Next readouts
- 2020-11-06
- 2026-03-16
Top conditions
- HIV Infections12
- Anemia11
- HIV Infection8
- Obesity8
- Cardiovascular Diseases6
- Tobacco Use Cessation6
- Heart Diseases5
- HIV/AIDS5
Frequently asked questions about Harvard School of Public Health (HSPH)
- How many clinical trials does Harvard School of Public Health (HSPH) have on ClinicalTrials.gov?
- Harvard School of Public Health (HSPH) is listed as the lead sponsor on 153 clinical trials in ClinicalTrials.gov, 18 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Harvard School of Public Health (HSPH)'s trials are in Phase 3?
- 20 of Harvard School of Public Health (HSPH)'s trials are in Phase 3, spread across 5 active drug programs.
- What therapeutic areas does Harvard School of Public Health (HSPH) focus on?
- Harvard School of Public Health (HSPH)'s most-studied conditions on ClinicalTrials.gov are HIV Infections, Anemia, HIV Infection, Obesity, Cardiovascular Diseases.
- When are Harvard School of Public Health (HSPH)'s next clinical trial readouts?
- Harvard School of Public Health (HSPH) has 2 upcoming primary-completion readouts tracked here; the soonest is “Early Infant HIV Treatment in Botswana”, expected around 2020-11-06.